Search Results - "Mootrey, G"

Refine Results
  1. 1

    Financing Immunization of Adults in the United States by Orenstein, W A, Mootrey, G T, Pazol, K, Hinman, A R

    Published in Clinical pharmacology and therapeutics (01-12-2007)
    “…Immunization is one of the most effective and cost‐effective prevention measures available.1 As a result of universal vaccination of children, polio has been…”
    Get full text
    Journal Article
  2. 2

    Intussusception Among Recipients of Rotavirus Vaccine: Reports to the Vaccine Adverse Event Reporting System by Zanardi, Lynn R, Haber, Penina, Mootrey, Gina T, Niu, Manette T, Wharton, Melinda, VAERS Working Group

    Published in Pediatrics (Evanston) (01-06-2001)
    “…Rotavirus vaccine was licensed on August 31, 1998, and subsequently recommended for routine use among infants. To assess rare adverse events, postlicensure…”
    Get full text
    Journal Article
  3. 3

    An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system by Singleton, James A., Lloyd, Jenifer C., Mootrey, Gina T., Salive, Marcel E., Chen, Robert T.

    Published in Vaccine (16-07-1999)
    “…We evaluated the Vaccine Adverse Event Reporting System (VAERS), the spontaneous reporting system for vaccine-associated adverse events in the United States,…”
    Get full text
    Journal Article
  4. 4

    Anaphylaxis from yellow fever vaccine by Kelso, John M., Mootrey, Gina T., Tsai, Theodore F.

    Published in Journal of allergy and clinical immunology (01-04-1999)
    “…Background: There are very few reports of anaphylactic reactions to yellow fever (YF) vaccine in the literature, and these date from the 1940s. Objective: We…”
    Get full text
    Journal Article
  5. 5

    The Adult Hepatitis Vaccine Project—California, 2007-2008 by Nickell, SP, Winter, K, Talarico, J, Bolan, G, Miller, J, McLean, R, King, H, Weinbaum, C, Holtzman, D, Ward, JW, Mootrey, G, Weiss, E, Yu, Y

    “…In 2006, when the Advisory Committee on Immunization Practices recommended that hepatitis B vaccination be offered to all adults as part of routine prevention…”
    Get full text
    Journal Article
  6. 6

    Infant Immunization With Acellular Pertussis Vaccines in the United States: Assessment of the First Two Years' Data From the Vaccine Adverse Event Reporting System (VAERS) by Braun, M. Miles, Mootrey, Gina T, Salive, Marcel E, Chen, Robert T, Ellenberg, Susan S, VAERS Working Group

    Published in Pediatrics (Evanston) (01-10-2000)
    “…To evaluate the safety of infant immunization with acellular pertussis vaccines in the United States. The US Food and Drug Administration approved the first…”
    Get full text
    Journal Article
  7. 7

    Postlicensure Safety Surveillance for Varicella Vaccine by Wise, Robert P, Salive, Marcel E, Braun, M. Miles, Mootrey, Gina Terracciano, Seward, Jane F, Rider, Lisa G, Krause, Philip R

    “…CONTEXT Since its licensure in 1995, the extensive use of varicella vaccine and close surveillance of the associated anecdotal reports of suspected adverse…”
    Get full text
    Journal Article
  8. 8

    Surveillance for Poliovirus Vaccine Adverse Events, 1991 to 1998: Impact of a Sequential Vaccination Schedule of Inactivated Poliovirus Vaccine Followed by Oral Poliovirus Vaccine by Wattigney, Wendy A, Mootrey, Gina T, Braun, M. Miles, Chen, Robert T

    Published in Pediatrics (Evanston) (01-05-2001)
    “…The elimination of wild-virus-associated poliomyelitis in the Western Hemisphere in 1991 and rapid progress in global polio eradication efforts changed the…”
    Get full text
    Journal Article
  9. 9

    Advanced age a risk factor for illness temporally associated with yellow fever vaccination by Martin, Michael, Weld, Leisa H, Tsai, Theodore F, Mootrey, Gina T, Chen, Robert T, Niu, Manette, Cetron, Martin S

    Published in Emerging infectious diseases (01-11-2001)
    “…In 1998, the Centers for Disease Control and Prevention was notified of severe illnesses and one death, temporally associated with yellow fever (YF)…”
    Get full text
    Journal Article
  10. 10

    Safety Data on Meningococcal Polysaccharide Vaccine from the Vaccine Adverse Event Reporting System by Ball, Robert, Braun, M. Miles, Mootrey, Gina T.

    Published in Clinical infectious diseases (01-05-2001)
    “…Recent recommendations by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices may lead to the increased use of the…”
    Get full text
    Journal Article
  11. 11

    Influenza Vaccination Coverage Among Children Aged 6–23 Months — United States, 2006–07 Influenza Season by Santibanez, T.A, Fiore, A, Mootrey, G

    “…Children aged <5 years have more influenza-related medical-care visits compared with older children, and those aged <2 years are at the greatest risk for…”
    Get full text
    Journal Article Newsletter
  12. 12

    State-Specific Influenza Vaccination Coverage Among Adults—United States, 2006-07 Influenza Season by Lu, PJ, Euler, GL, Mootrey, GT, Ahmed, F, Wooten, KG

    “…Data from the 2006 and 2007 Behavioral Risk Factor Surveillance System (BRFSS) surveys indicate that influenza vaccination coverage among adults for the…”
    Get full text
    Journal Article
  13. 13

    Challenges and controversies in immunization safety by Chen, R T, DeStefano, F, Pless, R, Mootrey, G, Kramarz, P, Hibbs, B

    “…No vaccine is perfectly safe or effective. As diseases such as diphtheria and polio fade, vaccine safety concerns, especially alleged links between…”
    Get more information
    Journal Article
  14. 14

    Adverse event reports following vaccination for Lyme disease: December 1998–July 2000 by Lathrop, Sarah L., Ball, Robert, Haber, Penina, Mootrey, Gina T., Braun, M.Miles, Shadomy, Sean V., Ellenberg, Susan S., Chen, Robert T., Hayes, Edward B.

    Published in Vaccine (22-02-2002)
    “…Context: The vaccine adverse event reporting system (VAERS) monitors vaccine safety post-licensure. Although events reported to VAERS are not necessarily…”
    Get full text
    Journal Article
  15. 15

    Influenza Vaccination Coverage Among Children Aged 6–23 Months — United States, 2005–06 Influenza Season by Santibanez, T.A, Santoli, J.M, Mootrey, G, Euler, G.L, Fiore, A

    “…Children aged <2 years are at increased risk for influenza-related hospitalizations, and those aged <5 years have more influenza-related health-care visits…”
    Get full text
    Journal Article Newsletter
  16. 16

    Safety of routine childhood vaccinations. An epidemiological review by Chen, R T, Mootrey, G, DeStefano, F

    Published in Paediatric drugs (01-07-2000)
    “…Immunisations have been one of the most cost-effective public health interventions in human history. Despite remarkable progress, several challenges face…”
    Get full text
    Journal Article
  17. 17

    The epidemiology of fatalities reported to the Vaccine Adverse Event Reporting System 1990-1997 by Silvers, Linda E., Ellenberg, Susan S., Wise, Robert P., Varricchio, Frederick E., Mootrey, Gina T., Salive, Marcel E.

    Published in Pharmacoepidemiology and drug safety (01-06-2001)
    “…Purpose To examine the fatalities reported to the federally administered Vaccine Adverse Event Reporting System (VAERS), a passive surveillance system, in its…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Prevalence of Anti-Gelatin IgE Antibodies in People With Anaphylaxis After Measles-Mumps-Rubella Vaccine in the United States by Pool, Vitali, Braun, M. Miles, Kelso, John M, Mootrey, Gina, Chen, Robert T, Yunginger, John W, Jacobson, Robert M, Gargiullo, Paul M

    Published in Pediatrics (Evanston) (01-12-2002)
    “…Anaphylaxis after immunization, although rare, is serious and potentially life-threatening. Understanding risk factors for this reaction is therefore…”
    Get full text
    Journal Article